Already Registered? Log In Now
Not Registered?
Business Email:
Complete this form to enter the webcast.
Already Registered?
(* indicates required field)
Complete this form to enter the webcast.
(* indicates required field)
Business Email*:
First Name*:
Last Name*:
Title*:
Company Name*:
Street Address 1*:
Street Address 2:
City*:
State/Province*:
--
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Postal Code*:
Country*:
--
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Macedonia, Republic of
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French Part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch Part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania, United Republic of
Thailand
Timor-leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Business Phone:
Which best describes your job function?:
--
Clinical Research
Commercial Operations
Commercialization
Compliance
Consultant
Contract Services
Corporate Management
Drug Safety
Engineering
Environmental
Finance
HR
IT
Lab Management
Legal
Managed Care
Manufacturing/Processing
Market Research
Marketing
Media Planning
Medical Affairs
Medicare/Medicaid
Meeting Planner
Other
Packaging
Patient Programs/Services
Pharmacy
Procurement
Project Management
QA/QC
R&D
Regulatory Affairs
Reimbursement
Sales Management
Scientific
Supply Chain
Technology Transfer
Trade/Sales
Validation
X-Outcomes
Which best describes your business/industry?:
--
Academic
Audit & Financial Advisory
Biopharma
Bio Pharmaceutical
Biotech
Consultant
Contract Manufacturing Organization (CMO)
Contract Research Organization (CRO)
Convention/Visitors Bureau
Data Management/Technology Provider
Diagnostics
DMC (Destination Management Company)
Food
Government
Health Plan/Payer
Hospital/Medical Centers
Hotel
Laboratory
Legal/Law Firm
Marketing/Creative Agency
Medical Device
Non Profit
PBM (Pharmacy Benefit Management)
Pharmaceutical
Retail Pharmacy
Solutions Provider
Third Party Meeting Manager
Wholesaler/Distributer
How many years have you worked in the pharmaceutical industry?:
How many years have you worked with host cell protein measurement?:
Do you use the USP-NF or USP Reference Standards in your current role?:
--
Yes
No
How did you learn about this webinar?:
checked
Yes, please subscribe me to BioPharm International's free e-newsletters.
By registering for this event, you agree to MJH Life Sciences ®
Terms and Conditions
,
Privacy Policy
, and understand your data will be used by MJH and its affiliates for amongst other things, alerting you to other services or products that you maybe interested in, and may be shared with or sold to third parties for their use, including possible contact with you through email or other communications, consistent with their respective privacy policy. If you do not agree to have your data used in this way, please contact
info@mjhassoc.com
.
*Denotes required.
Best Practices for Residual Host Cell Protein Measurement in Biopharmaceuticals by Mass Spectrometry: USP Chapter 1132.1
Wed, May 31, 2023 11:00 AM EDT{LOCAL_TZ}
Event Overview
Protein-based biotherapeutics are produced by numerous prokaryotic and eukaryotic cellular expression systems. During the manufacture of these products, host cell proteins (HCPs) are a significant class of process-related impurities that are coproduced with the desired product.
USP
General Chapter <1132>
Residual Host Cell Protein Measurement in Biopharmaceuticals
includes detailed information on the design, validation, and implementation of reagents and immunoassays used to measure these residual HCPs. A new proposed chapter builds on <1132> and provides an overview of the capability of Mass Spectrometry (MS) methods for HCP identification and quantitation. This seminar will describe best practices for instrument selection, sample preparation, liquid chromatography (LC) separation, MS data acquisition, MS data analysis and reporting, with particular attention to the orthogonality of MS and traditional methods.
Key Learning Objectives
To understand the importance of Host Cell Protein Analysis in biopharmaceutical development.
To become familiar with current technologies and best practices for analysis of HCP by LC-MS
To understand the applications for and orthogonal relationship of LC-MS and traditional methods for HCP analysis.
Who Should Attend
Scientists, managers and regulatory experts responsible for manufacture and testing of biologics destined for clinical trials.
Featured Speakers
Niomi Peckham
Director of Pipeline Development, Global Biologics
United States Pharmacopeia
Niomi
Peckham
is the Director of Pipeline Development in USP Global Biologics. She works with scientific experts and stakeholders to develop standards for assays used to support biopharmaceutical quality assessment and development. Niomi has worked for several biotechnology and diagnostic companies but has spent most of her career at Pfizer and Alexion Pharmaceuticals, focusing on development of protein-based biopharmaceuticals. She has been responsible for development, validation, transfer, and lifecycle management of analytical methods for biopharmaceuticals from pre-clinical through commercialization. Her particular focus has been on analysis of host cell proteins.
Niomi holds a Bachelor of Science in Biotechnology from the University of Connecticut, a Master of Science in Molecular and Cellular Biology from the State University of New York at Stony Brook, and a Graduate Certificate in Drug Development from Temple University.
Speaker’s Email:
niomi.peckham@USP.org
Speaker’s LinkedIn:
https://www.linkedin.com/in/niomi-peckham/
Ned Mozier
Vice President, Biotherapeutics Pharmaceutical Sciences
Pfizer
Ned Mozier
group is responsible for CMC teams for 40-50 projects in Pfizer clinical trials, including the coordination of authoring and reviewing of regulatory submissions to assure on-time delivery. This group is responsible for BTxPS committees that manage the early projects entering Pfizer’s pipeline and resolve key project conflicts and authorize critical strategies. Achievement of key milestones (within budget and on time) as well as risks of delay or major budget change are communicated proactively. Milestone goals and achievements are tracked for all standard, accelerated, and Lightspeed projects. His group manages the internal manufacturing capacity as well as the outsourcing function, in which smooth transitions of projects from early to later stages are a priority. Project leadership and management from this group contributes to Pfizer’s mission of delivering 25 breakthrough products to patients by 2025. The transfer of out-licensed projects is also managed in collaboration with the Transformative Technology group.
Ned obtained his Ph.D. in biochemistry from the University of Louisville in 1988, which prepared him for a career in the biotechnology sector. After postdoctoral research at The Upjohn Company and two years at Baxter Healthcare’s blood substitutes division, Ned has worked for Pfizer and legacy companies. He has led co-development projects and contributed to many approved products, including establishment of the structure function relationships for biosimilars.
Speaker’s Email:
ned.m.mozier@pfizer.com
Speaker’s LinkedIn:
https://www.linkedin.com/in/ned-mozier-49970a11
For any technical questions please contact
Jorge de la Bandera
:
JdelaBandera@mjhlifesciences.com
Protein-based biotherapeutics are produced by numerous prokaryotic and eukaryotic cellular expression systems. During the manufacture of these products, host cell proteins (HCPs) are a significant class of process-related impurities that are coproduced with the desired product.
USP
General Chapter <1132>
Residual Host Cell Protein Measurement in Biopharmaceuticals
includes detailed information on the design, validation, and implementation of reagents and immunoassays used to measure these residual HCPs. A new proposed chapter builds on <1132> and provides an overview of the capability of Mass Spectrometry (MS) methods for HCP identification and quantitation. This seminar will describe best practices for instrument selection, sample preparation, liquid chromatography (LC) separation, MS data acquisition, MS data analysis and reporting, with particular attention to the orthogonality of MS and traditional methods.
Key Learning Objectives:
To understand the importance of Host Cell Protein Analysis in biopharmaceutical development.
To become familiar with current technologies and best practices for analysis of HCP by LC-MS
To understand the applications for and orthogonal relationship of LC-MS and traditional methods for HCP analysis.
Who Should Attend:
Scientists, managers and regulatory experts responsible for manufacture and testing of biologics destined for clinical trials.
FAQs and System Test
Outlook ❯
Google ❯